v3.24.3
Equity (Tables)
9 Months Ended
Sep. 30, 2024
Stockholders' Equity Note [Abstract]  
Summary of Common Stock Activity

The following table summarizes the common stock activity for the three and nine months ended September 30, 2024 and 2023, respectively.

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Balance, beginning of period

 

 

116,608,522

 

 

 

101,938,376

 

 

 

102,832,103

 

 

 

101,804,454

 

Issuance of common stock

 

 

4,163,118

 

 

 

96,891

 

 

 

17,939,537

 

 

 

230,813

 

Balance, end of period

 

 

120,771,640

 

 

 

102,035,267

 

 

 

120,771,640

 

 

 

102,035,267

 

On July 9, 2024, at the Annual Meeting of Stockholders, our stockholders approved an amendment and restatement of our certificate of incorporation to increase the number of authorized shares of our common stock from 200,000,000 shares to 600,000,000 shares, which remains unchanged after the reverse stock split. Please see Note 15 - Subsequent Events for further detail regarding the reverse stock split.

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following table summarizes the instruments excluded from the calculations of diluted shares outstanding because the effect of including them would have been anti-dilutive.

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 



2024

 



2023

 

 

2024

 



2023

 

Dividend Warrants

 

45,128,594

 

 

 

-

 

 

 

45,128,594

 

 

 

-

 

Convertible Notes

 

21,496,042

 

 

 

22,250,040

 

 

 

21,496,042

 

 

 

22,250,040

 

Common Warrants

 

15,000,000

 

 

 

-

 

 

 

15,000,000

 

 

 

-

 

Employee stock options

 

9,219,006

 

 

 

11,900,448

 

 

 

9,219,006

 

 

 

11,900,448

 

Private Warrants

 

3,914,525

 

 

 

3,914,525

 

 

 

3,914,525

 

 

 

3,914,525

 

Restricted stock and RSUs

 

2,655,281

 

 

 

2,295,337

 

 

 

2,655,281

 

 

 

2,295,337

 

Stock appreciation rights

 

1,732,854

 

 

 

-

 

 

 

1,732,854

 

 

 

-

 

Senior Secured Term Loan Warrants

 

1,500,000

 

 

 

1,500,000

 

 

 

1,500,000

 

 

 

1,500,000

 

Performance stock

 

1,124,978

 

 

 

127,770

 

 

 

1,124,978

 

 

 

127,770

 

Legacy Danimer options

 

125,492

 

 

 

125,492

 

 

 

125,492

 

 

 

125,492

 

Total excluded instruments

 

101,896,772

 

 

 

42,113,612

 

 

 

101,896,772

 

 

 

42,113,612